Career history of Phillip Gutry
Former positions of Phillip Gutry
| Companies | Position | Start | End |
|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Director/Board Member | 31/03/2015 | 31/10/2021 |
| Independent Dir/Board Member | 31/03/2015 | 31/10/2021 | |
| KRONOS BIO, INC. | Corporate Officer/Principal | 30/09/2018 | 30/09/2020 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/05/2015 | 30/09/2018 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 31/12/2010 | 31/05/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 31/07/2006 | 30/04/2011 |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Corporate Officer/Principal | 31/12/1995 | 30/06/1998 |
| LENZ THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | 31/03/2022 |
| Director of Finance/CFO | 30/09/2020 | 31/03/2022 | |
| Investor Relations Contact | 30/09/2020 | 31/03/2022 | |
| Corporate Officer/Principal | 31/03/2022 | - | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Director/Board Member | - | - |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Phillip Gutry
| Dartmouth College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistics
International
| United States | 13 |
Operational
| Corporate Officer/Principal | 6 |
| Director/Board Member | 3 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 7 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| Private companies | 6 |
|---|---|
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Riverside Partners LLC
 Riverside Partners LLC Investment ManagersFinance Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts. | Finance |
Wilkerson Group
Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Health Services |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Retail Trade |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Phillip Gutry
- Experience
